Novo Nordisk (NVO) Q3 2023 Earnings Call Transcript

NVO earnings call for the period ending September 30, 2023.

Related Keywords

United States ,Philadelphia ,Pennsylvania ,China ,Denmark ,Chinese ,Danish ,America ,American ,Michael Nedelcovych ,Societe Generale ,Inversago Pharma ,Peter Welford Jefferies ,Doug Langa ,Mattias Haggblom ,Peter Welford ,Mark Purcell ,Richard Vosser Jpmorgan ,Simon Baker Redburn ,Richard Parkes Exane ,Richard Vosser ,Naresh Chouhan ,Florent Cespedes Societe Generale ,Mattias Haggblom Handelsbanken ,Daniel Bohsen ,Seamus Fernandez Guggenheim ,Pete Verdult Citi ,Florence Cespedes ,Michael Novod ,Karsten Munk Knudsen ,Richard Parkes ,Seamus Fernandez ,Novo Nordisk ,Martin Holst Lange ,Mark Purcell Morgan Stanley ,Simon Baker ,Emmanuel Papadakis ,Lars Fruergaard Jorgensen ,Michael Novod Nordea ,Camilla Sylvest ,Peter Verdult ,European Medicines Agency ,American Heart Association Congress ,Nordea ,Naresh Chouhan Intron Health Analyst ,Head Of Development ,Citigroup ,Corporate Affairs ,Morgan Stanley ,Company Analyst ,Handelsbanken ,Intron Health ,Astrazeneca ,Emmanuel Papadakis Deutsche Bank Analyst ,Data Monitoring Committee ,Barclays ,American Heart Association ,North America ,Karsten Munk ,Motley Fool Stock Advisor ,Stock Advisor ,Chief Executive ,Vice President ,Commercial Strategy ,European Medicines ,Chief Financial ,Forma Therapeutics ,American Heart ,Emily Field ,Capital Markets ,Guggenheim Partners ,Redburn Partners ,